Tag Archives: CD4 Counts

WHO Official: "Prevention and Treatment Are Two Faces of the Same Coin"

By on .

The idea of HIV treatment as prevention got a major boost yesterday in the wake of a WHO meeting in Geneva on the use of antiretroviral therapy as a way to curb new HIV infections. “In the past, there has been a false dichotomy between prevention and treatment,” Teguest Guerma, interim director of the WHO’s […]

Goosby Takes on Hot Topics at State Department Session

By on .

As Obama’s new global AIDS coordinator, Dr. Eric Goosby has no shortage of burning issues on his plate—from reports of ARV stock-outs in the developing world to questions about the long-term sustainability of PEPFAR. At a 1 ½ hour community meeting at the State Department Friday, the unassuming California doctor tried to reassure the global […]

What Keeps Dr. Eric Goosby Up at Night?

By on .

You’ll find the answer to that question, and other fresh insights into the Administration’s plans for PEPFAR, in this ScienceInsider interview with Dr. Goosby, President Obama’s global AIDS coordinator. Among the highlights, Dr. Goosby tells SI that efforts to nix the ban on needle-exchange programs are well underway within the Administration and the PEPFAR office. […]

Cahn Addresses the Latest (Hot-Button) HIV Treatment Topics

By on .

This post is by Center Director Christine Lubinski, reporting from the 2009 IAS conference in Cape Town. Pedro Cahn, president of Huésped Foundation, an Argentinean AIDS organization involved in HIV/AIDS clinical research, prevention and care, offered a refreshingly candid and provocative HIV treatment update as the second plenary speaker at the IAS conference today. Cahn, […]

Earlier ART=Better Chance for Survival

By on .

In a significant development, the National Institute of Allergy and Infectious Diseases announced that it a trial in Haiti–investigating the impact of earlier ART therapy in HIV-positive patients—would be ended early because the results were overwhelming; the findings showed that HIV-infected adults are more likely to survive if they start antiretroviral drugs before their immune […]